Free Trial
NASDAQ:ALGN

Align Technology (ALGN) Stock Price, News & Analysis

Align Technology logo
$190.25 -2.56 (-1.33%)
As of 12:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Align Technology Stock (NASDAQ:ALGN)

Key Stats

Today's Range
$187.72
$193.53
50-Day Range
$170.80
$204.48
52-Week Range
$141.74
$263.24
Volume
420,653 shs
Average Volume
1.04 million shs
Market Capitalization
$13.79 billion
P/E Ratio
34.65
Dividend Yield
N/A
Price Target
$242.92
Consensus Rating
Moderate Buy

Company Overview

Align Technology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

ALGN MarketRank™: 

Align Technology scored higher than 97% of companies evaluated by MarketBeat, and ranked 87th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Align Technology has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 9 buy ratings, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Align Technology has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Align Technology's stock forecast and price target.
  • Earnings Growth

    Earnings for Align Technology are expected to grow by 12.16% in the coming year, from $7.98 to $8.95 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Align Technology is 34.90, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.74.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Align Technology is 34.90, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.59.

  • Price to Earnings Growth Ratio

    Align Technology has a PEG Ratio of 2.11. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Align Technology has a P/B Ratio of 3.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Align Technology's valuation and earnings.
  • Percentage of Shares Shorted

    4.14% of the float of Align Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Align Technology has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Align Technology has recently decreased by 6.95%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Align Technology does not currently pay a dividend.

  • Dividend Growth

    Align Technology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.14% of the float of Align Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Align Technology has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Align Technology has recently decreased by 6.95%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Align Technology has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Align Technology this week, compared to 14 articles on an average week.
  • Search Interest

    Only 4 people have searched for ALGN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Align Technology to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Align Technology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.66% of the stock of Align Technology is held by insiders.

  • Percentage Held by Institutions

    88.43% of the stock of Align Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Align Technology's insider trading history.
Receive ALGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.

ALGN Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Align Technology (NASDAQ:ALGN) Price Target Raised to $220.00
ALGN Stock Price Quote - Morningstar
See More Headlines

ALGN Stock Analysis - Frequently Asked Questions

Align Technology's stock was trading at $208.51 at the beginning of the year. Since then, ALGN shares have decreased by 8.0% and is now trading at $191.7320.

Align Technology, Inc. (NASDAQ:ALGN) posted its quarterly earnings results on Wednesday, April, 30th. The medical equipment provider reported $2.13 EPS for the quarter, topping the consensus estimate of $2.00 by $0.13. Align Technology's quarterly revenue was down 1.8% on a year-over-year basis.
Read the conference call transcript
.

Align Technology's Board of Directors initiated a stock buyback plan on Tuesday, May 6th 2025, which permits the company to repurchase $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 7.9% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board believes its stock is undervalued.

Align Technology subsidiaries include exocad Global Holdings GmbH (“exocad”), G.L. Dental Couture, Cadent, and Align Technology Switzerland GmbH.

Align Technology's top institutional investors include Swedbank AB (0.58%), Riverbridge Partners LLC (0.29%), Argent Capital Management LLC (0.16%) and Assenagon Asset Management S.A. (0.04%). Insiders that own company stock include Joseph M Hogan, Joseph Lacob, Warren S Thaler, C Raymond Larkin Jr, Kevin J Dallas, John Morici and Emory Wright.
View institutional ownership trends
.

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Align Technology investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Visa (V) and PayPal (PYPL).

Company Calendar

Last Earnings
4/30/2025
Today
7/16/2025
Next Earnings (Confirmed)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ALGN
CIK
1097149
Employees
20,945
Year Founded
1997

Price Target and Rating

High Price Target
$280.00
Low Price Target
$170.00
Potential Upside/Downside
+26.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
$5.49
Trailing P/E Ratio
35.12
Forward P/E Ratio
24.16
P/E Growth
2.11
Net Income
$421.36 million
Net Margins
10.29%
Pretax Margin
14.85%
Return on Equity
13.52%
Return on Assets
8.36%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.21
Quick Ratio
1.08

Sales & Book Value

Annual Sales
$4.00 billion
Price / Sales
3.50
Cash Flow
$8.70 per share
Price / Cash Flow
22.17
Book Value
$51.60 per share
Price / Book
3.74

Miscellaneous

Outstanding Shares
72,490,000
Free Float
72,007,000
Market Cap
$13.98 billion
Optionable
Optionable
Beta
1.63

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ALGN) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners